AMICUS THERAPEUTICS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Amicus Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q3 2024.
  • Amicus Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 305M shares, a 3.02% increase year-over-year.
  • Amicus Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 295M shares, a 2.11% increase from 2022.
  • Amicus Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 289M shares, a 6.5% increase from 2021.
  • Amicus Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 271M shares, a 4.85% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 305M +8.93M +3.02% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 304M +11M +3.75% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 303M +11.6M +3.97% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 295M +6.11M +2.11% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 296M +6.54M +2.26% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 293M +826K +0.28% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 291M +2.86M +0.99% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 289M +17.6M +6.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 289M +21.8M +8.14% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 292M +25.6M +9.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 288M +24.1M +9.12% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 271M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 267M +8.3M +3.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 266M +8.43M +3.27% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 264M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 259M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 258M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.